Literature DB >> 21528098

Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles.

Yeu-Chun Kim1, Fu-Shi Quan, Jae-Min Song, Aswani Vunnava, Dae-Goon Yoo, Kyoung-Mi Park, Richard W Compans, Sang-Moo Kang, Mark R Prausnitz.   

Abstract

Morbidity and mortality due to seasonal and pandemic influenza could be reduced by simpler vaccination methods that enable improved vaccination coverage. In this study, solid metal microneedles coated with influenza virus-like particle (VLP) vaccine were inserted into skin for intradermal immunization. Microneedles were applied to the skin by hand and designed for simple administration with little or no training. Inclusion of trehalose in the coating formulation significantly increased vaccine stability during coating by maintaining hemagglutination activity. Mice vaccinated with stabilized microneedles developed strong antibody responses comparable to conventional intramuscular vaccination and were fully protected against subsequent viral challenge. Whereas, coating microneedles with a coating solution lacking trehalose led to only partial protection against lethal viral challenge. Therefore, our results show that microneedles coated with trehalose-stabilized VLP vaccine can be a promising tool for improving influenza vaccination.

Entities:  

Year:  2010        PMID: 21528098      PMCID: PMC3082143          DOI: 10.1016/j.provac.2010.03.004

Source DB:  PubMed          Journal:  Procedia Vaccinol


  16 in total

1.  Estimation of hemagglutination-inhibition titers.

Authors:  S Horváth
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

2.  Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

Authors:  Fu-Shi Quan; Chunzi Huang; Richard W Compans; Sang-Moo Kang
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

3.  Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.

Authors:  Isabel Leroux-Roels; Eva Vets; Ralf Freese; Michael Seiberling; Françoise Weber; Camille Salamand; Geert Leroux-Roels
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

Review 4.  The biology of influenza viruses.

Authors:  Nicole M Bouvier; Peter Palese
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

5.  Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Dae-Goon Yoo; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

6.  Improved influenza vaccination in the skin using vaccine coated microneedles.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Dae-Goon Yoo; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  Vaccine       Date:  2009-09-15       Impact factor: 3.641

7.  Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  J Control Release       Date:  2009-10-17       Impact factor: 9.776

Review 8.  Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans.

Authors:  J S Malik Peiris; Leo L M Poon; Yi Guan
Journal:  J Clin Virol       Date:  2009-06-11       Impact factor: 3.168

9.  Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge.

Authors:  Qiyun Zhu; Vladimir G Zarnitsyn; Ling Ye; Zhiyuan Wen; Yulong Gao; Lei Pan; Ioanna Skountzou; Harvinder S Gill; Mark R Prausnitz; Chinglai Yang; Richard W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-27       Impact factor: 11.205

10.  Transdermal influenza immunization with vaccine-coated microneedle arrays.

Authors:  Dimitrios G Koutsonanos; Maria del Pilar Martin; Vladimir G Zarnitsyn; Sean P Sullivan; Richard W Compans; Mark R Prausnitz; Ioanna Skountzou
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

View more
  10 in total

Review 1.  Microneedle Coating Methods: A Review with a Perspective.

Authors:  Rohan S J Ingrole; Harvinder Singh Gill
Journal:  J Pharmacol Exp Ther       Date:  2019-06-07       Impact factor: 4.030

Review 2.  Cutaneous immunization: an evolving paradigm in influenza vaccines.

Authors:  Harvinder S Gill; Sang-Moo Kang; Fu-Shi Quan; Richard W Compans
Journal:  Expert Opin Drug Deliv       Date:  2014-02-12       Impact factor: 6.648

Review 3.  The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization.

Authors:  Kamran Badizadegan; James L Goodson; Paul A Rota; Kimberly M Thompson
Journal:  Expert Rev Vaccines       Date:  2020-03-17       Impact factor: 5.217

Review 4.  Microneedles for drug and vaccine delivery.

Authors:  Yeu-Chun Kim; Jung-Hwan Park; Mark R Prausnitz
Journal:  Adv Drug Deliv Rev       Date:  2012-05-01       Impact factor: 15.470

5.  Progress in microneedle array patch (MAP) for vaccine delivery.

Authors:  Thuy Trang Nguyen; Yujeong Oh; Yunseo Kim; Yura Shin; Seung-Ki Baek; Jung-Hwan Park
Journal:  Hum Vaccin Immunother       Date:  2020-07-15       Impact factor: 3.452

6.  Protective Efficacy of H9N2 Avian Influenza Vaccines Inactivated by Ionizing Radiation Methods Administered by the Parenteral or Mucosal Routes.

Authors:  Alessio Bortolami; Eva Mazzetto; Richard Thiga Kangethe; Viskam Wijewardana; Mario Barbato; Luca Porfiri; Silvia Maniero; Elisa Mazzacan; Jane Budai; Sabrina Marciano; Valentina Panzarin; Calogero Terregino; Francesco Bonfante; Giovanni Cattoli
Journal:  Front Vet Sci       Date:  2022-07-11

Review 7.  Microneedle Transdermal Drug Delivery Systems for Allergen-Specific Immunotherapy, Skin Disease Treatment, and Vaccine Development.

Authors:  Chang Ook Park; Hye Li Kim; Jung-Won Park
Journal:  Yonsei Med J       Date:  2022-10       Impact factor: 3.052

Review 8.  Microneedle patches for vaccine delivery.

Authors:  Hyemee Suh; Juhyung Shin; Yeu-Chun Kim
Journal:  Clin Exp Vaccine Res       Date:  2013-12-18

9.  Trehalose prevents aggregation of exosomes and cryodamage.

Authors:  Steffi Bosch; Laurence de Beaurepaire; Marie Allard; Mathilde Mosser; Claire Heichette; Denis Chrétien; Dominique Jegou; Jean-Marie Bach
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

10.  Optimizing extracellular vesicles' isolation from chronic lymphocytic leukemia patient plasma and cell line supernatant.

Authors:  Sara Elgamal; Emanuele Cocucci; Ellen J Sass; Xiaokui M Mo; Angela R Blissett; Edward P Calomeni; Kerry A Rogers; Jennifer A Woyach; Seema A Bhat; Natarajan Muthusamy; Amy J Johnson; Karilyn T Larkin; John C Byrd
Journal:  JCI Insight       Date:  2021-08-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.